Please try another search
| Name | Net % | Long % | Short % |
|---|---|---|---|
| Cash | 4.21 | 4.21 | 0.00 |
| Shares | 94.10 | 94.10 | 0.00 |
| Other | 1.69 | 1.69 | 0.00 |
| Ratios | Value | Category Average |
|---|---|---|
| P/E Ratio | 17.26 | 19.29 |
| Price to Book | 5.20 | 4.23 |
| Price to Sales | 8.01 | 2.39 |
| Price to Cash Flow | 16.72 | 15.49 |
| Dividend Yield | 0.98 | 1.12 |
| 5 Years Earnings Growth | 9.76 | 11.01 |
Number of long holdings: 81
Number of short holdings: 1
| Name | ISIN | Weight % | Last | Change % | |
|---|---|---|---|---|---|
| AbbVie | US00287Y1091 | 18.65 | 232.29 | -0.40% | |
| Alnylam | US02043Q1076 | 8.11 | 453.94 | +0.27% | |
| Gilead | US3755581036 | 5.64 | 125.20 | +1.46% | |
| argenx ADR | US04016X1019 | 4.65 | 891.72 | +0.21% | |
| Ascendis Pharma AS | US04351P1012 | 4.48 | 206.45 | +3.63% | |
| Insmed | US4576693075 | 3.32 | 190.95 | -1.77% | |
| Amgen | US0311621009 | 2.83 | 336.00 | -0.08% | |
| Uniqure NV | NL0010696654 | 2.70 | 30.350 | +0.76% | |
| Viridian Therapeutics | US92790C1045 | 2.32 | 28.49 | -1.55% | |
| Cogent Biosciences | US19240Q2012 | 2.25 | 33.810 | -4.11% |
| Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
|---|---|---|---|---|---|---|
| Fidelity 500 Index Institutional Pr | 736.94B | 17.50 | 22.66 | 14.62 | ||
| Fidelity Contrafund | 163.06B | 19.86 | 31.10 | 16.58 | ||
| Fidelity Total Market Index Instl b | 122.54B | 16.87 | 21.85 | 14.04 | ||
| Fidelity Blue Chip Growth | 73.54B | 20.19 | 35.44 | 19.59 | ||
| Fidelity Growth Company | 73.1B | 18.62 | 34.67 | 21.18 |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review